Positive feedbacks of coagulation: their role in threshold regulation.

Tissue factor (TF), the initiator of coagulation, continuously circulates in the plasma, and the clotting system "idles," generating very low levels of active clotting enzymes, clotting products, and by-products. Given the enormous amplification potential of the clotting cascade, rigorous control is required to ensure that such low-level stimulation does not cause massive system amplification and response. We propose that among the various mechanisms of regulation, activation thresholds may play a major role. These arise when positive-feedback reactions, of which there are several in the clotting system, are regulated by inhibitors. Such thresholds act like switches, so that small stimuli and/or nonproductive local conditions will generate no response, whereas larger stimuli or the existence of local prothrombotic conditions will produce a full, explosive response. We review here the evidence for system idling, the structures of the various feedback mechanisms of clotting, the mechanisms by which they can produce threshold behavior, and the possible role of thresholds in system regulation.

[1]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[2]  R. Macfarlane An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[3]  S. Levine,et al.  Enzyme Amplifier Kinetics , 1966, Science.

[4]  R. Canfield,et al.  Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.

[5]  B. Osterud,et al.  Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. , 1979, Blood.

[6]  J. Dunn,et al.  Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.

[7]  J. Jesty,et al.  The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin. , 1981, Blood.

[8]  W. Owen,et al.  Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. , 1982, The Journal of clinical investigation.

[9]  R. Bertina,et al.  Activation of Human Coagulation Factor VIII by Activated Factor X, the Common Product of the Intrinsic and the Extrinsic Pathway of Blood Coagulation , 1982, Thrombosis and Haemostasis.

[10]  M. Griffith,et al.  Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. , 1983, The Journal of clinical investigation.

[11]  P. Lollar,et al.  Reaction of antithrombin III with thrombin bound to the vascular endothelium. Analysis in a recirculating perfused rabbit heart preparation. , 1984, The Journal of biological chemistry.

[12]  K. Mann,et al.  Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. , 1984, The Journal of clinical investigation.

[13]  P. Lollar,et al.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. , 1984, Blood.

[14]  J Jesty,et al.  The kinetics of inhibition of alpha-thrombin in human plasma. , 1986, The Journal of biological chemistry.

[15]  M. Richardson,et al.  On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro. , 1986, Blood.

[16]  J. Jesty Analysis of the generation and inhibition of activated coagulation factor X in pure systems and in human plasma. , 1986, The Journal of biological chemistry.

[17]  R. Ralph,et al.  A speculation on the nature of chromosomal DNA. , 1988, Journal of theoretical biology.

[18]  Susan G. Brown,et al.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.

[19]  M A Khanin,et al.  A mathematical model of the kinetics of blood coagulation. , 1989, Journal of theoretical biology.

[20]  K. Nakamura,et al.  Measuring tissue factor (factor III) activity in plasma. , 1989, Clinical chemistry.

[21]  H. Hemker,et al.  In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. , 1989, Blood.

[22]  M. Bednarek,et al.  DETECTION OF FACTOR X ACTIVATION IN HUMANS , 1989, Thrombosis and Haemostasis.

[23]  H. ten Cate,et al.  Factor IX is activated in vivo by the tissue factor mechanism. , 1990, Blood.

[24]  Jean Pieters,et al.  Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma. , 1990, Blood.

[25]  W. Kisiel,et al.  Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. , 1991, Biochemistry.

[26]  Interaction of feedback control and product inhibition in the activation of factor X by factors IXa and VIII. , 1991, Haemostasis.

[27]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[28]  W. Kisiel,et al.  Tissue factor-dependent autoactivation of human blood coagulation factor VII. , 1992, The Journal of biological chemistry.

[29]  J. Jesty,et al.  Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate. , 1992, Archives of biochemistry and biophysics.

[30]  P. Neuenschwander,et al.  Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. , 1992, The Journal of biological chemistry.

[31]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .

[32]  E. Beltrami,et al.  Mathematical analysis of a proteolytic positive-feedback loop: dependence of lag time and enzyme yields on the initial conditions and kinetic parameters. , 1993, Biochemistry.

[33]  F. Ataullakhanov,et al.  Calcium threshold in human plasma clotting kinetics. , 1994, Thrombosis research.

[34]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, Journal of Biological Chemistry.

[35]  T. Koyama,et al.  Determination of plasma tissue factor antigen and its clinical significance , 1994, British journal of haematology.

[36]  U. Hedin,et al.  Thrombogenicity of the Injured Vessel Wall – Role of Antithrombin and Heparin , 1994, Thrombosis and Haemostasis.

[37]  D. Hoppensteadt,et al.  Tissue factor antigen levels in various biological fluids , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[38]  Y. Nemerson,et al.  Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface. , 1995, Biophysical journal.

[39]  J Jesty,et al.  Mathematical analysis of activation thresholds in enzyme-catalyzed positive feedbacks: application to the feedbacks of blood coagulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Altieri,et al.  Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. , 1996, The Biochemical journal.

[41]  I. Tsuji,et al.  Increased plasma tissue factor levels in acute myocardial infarction. , 1997, American heart journal.

[42]  Kenneth G. Mann,et al.  Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II* , 1997, The Journal of Biological Chemistry.

[43]  A. Gori,et al.  Elevated Tissue Factor and Tissue Factor Pathway Inhibitor Circulating Levels in Ischaemic Heart Disease Patients , 1998, Thrombosis and Haemostasis.

[44]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Badimón,et al.  Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.

[46]  P. Walsh,et al.  Thrombin-mediated Feedback Activation of Factor XI on the Activated Platelet Surface Is Preferred over Contact Activation by Factor XIIa or Factor XIa* , 2000, The Journal of Biological Chemistry.

[47]  H. K. Kim,et al.  Changes of Plasma Tissue Factor and Tissue Factor Pathway Inhibitor Antigen Levels and Induction of Tissue Factor Expression on the Monocytes in Coronary Artery Disease , 2000, Cardiology.

[48]  N. Mackman,et al.  Measurement of Tissue Factor Activity in Whole Blood , 2000, Thrombosis and Haemostasis.

[49]  J Jesty,et al.  The role of membrane patch size and flow in regulating a proteolytic feedback threshold on a membrane: possible application in blood coagulation. , 2001, Mathematical biosciences.

[50]  A. Fogelson,et al.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. , 2001, Biophysical journal.

[51]  J. Fallon,et al.  In situ localization of tissue factor in human thrombi. , 2002, Blood.

[52]  K. C. Jones,et al.  A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.

[53]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[54]  Sharene D. Bungay,et al.  A mathematical model of lipid-mediated thrombin generation. , 2003, Mathematical medicine and biology : a journal of the IMA.

[55]  Y. Nemerson,et al.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein , 2003, Nature Medicine.

[56]  Nigel Mackman,et al.  Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. , 2004, Blood.

[57]  G. Lip,et al.  Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus: Relationships to Cardiovascular Disease and Risk Factor Intervention , 2004, Circulation.

[58]  J. Silveira,et al.  Unique in Vivo Modifications of Coagulation Factor V Produce a Physically and Functionally Distinct Platelet-derived Cofactor , 2004, Journal of Biological Chemistry.

[59]  E. Beltrami,et al.  Demonstration of a Threshold Response in a Proteolytic Feedback System: Control of the Autoactivation of Factor XII , 2006, Pathophysiology of Haemostasis and Thrombosis.

[60]  K. Mann,et al.  Tissue factor activity in whole blood. , 2005, Blood.

[61]  P. Walsh Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor-XI activation by thrombin. , 2007, Biochemistry.